Products - Structural heart defects | Topic | NICE

Showing 8 products

Date | Title

Status: In developmentRemove ‘Status: In development’ filter

Vutrisiran for treating transthyretin-related amyloidosis cardiomyopathy [ID6470]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
10 December 2025
Acoramidis for treating transthyretin-related amyloidosis cardiomyopathy [ID6354]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
14 January 2026
Off-pump minimal access mitral valve repair by artificial chordae insertion to treat mitral regurgitation
Status:
In development
Programme:
Interventional procedures guidance
Expected publication date:
4 March 2026
Transcatheter tricuspid valve implantation for symptomatic severe tricuspid regurgitation
Status:
In development
Programme:
Interventional procedures guidance
Expected publication date:
4 March 2026
Mavacamten for treating symptomatic non-obstructive hypertrophic cardiomyopathy [ID6523]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Aficamten for treating symptomatic obstructive hypertrophic cardiomyopathy ID6575
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Heart valve disease presenting in adults: investigation and management - transcatheter aortic valve implantation (TAVI) to treat aortic stenosis (update)
Status:
In development
Programme:
NICE guideline
Expected publication date:
TBC
Heart valve disease presenting in adults: investigation and management (transcatheter aortic valve implantation (TAVI) to treat aortic stenosis)
Status:
In development
Programme:
NICE guideline
Expected publication date:
TBC